InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Jacobs Bette. Director active across 1 company, notably Shuttle Pharmaceuticals Holdings, Inc.. Aggregated, 2 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €8k. Activity tracked since 29 December 2022. The latest transaction was filed on 13 December 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations